Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.
Condition: Metastatic Breast Cancer Interventions: Drug: Disulfiram; Drug: Vinorelbin; Drug: Cisplatin; Drug: Copper Sponsor: National Cancer Institute, Slovakia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 11, 2020 Category: Research Source Type: clinical trials
Determination of ClotPro Paediatric Reference Range Study
Conditions: Clotting and Bleeding Disorders; Child Development; Infant Development; Coagulopathy Intervention: Diagnostic Test: thromboelastometry test (TEM test) Sponsor: National Institute of Children's Diseases, Slovakia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2019 Category: Research Source Type: clinical trials